Exploring and expanding the medical uses for cannabis is an important focus for ICC.
As well as making potentially valuable contributions to medical science, commercially it is an area with significant potential. Cannabinoids have already been shown to combat diseases and minimize a number of different symptoms.
The cannabinoids are extracted by the Co2 supercritical method, guaranteeing higher quality and maximizing its properties without using chemicals.
We will produce high quality certified organic hemp to produce GMP grade pure CBD (95% +) crystals. In the meantime, our R&D team is working to develop pharmaceutical cannabis products adapted for a varied and changing international demand.